Davis Polk advised the representatives of the several underwriters in connection with the $296 million SEC-registered offering of 9,545,000 shares of common stock of 1Life Healthcare, Inc. by certain existing stockholders of 1Life Healthcare, including 1,245,000 shares of common stock sold pursuant to the full exercise of the underwriters’ option to purchase additional shares. 1Life Healthcare’s common stock is listed on the Nasdaq Global Select Market under the symbol “ONEM.”

Operating under the “One Medical” brand, 1Life Healthcare is a membership-based primary care platform with seamless digital health and inviting in-office care. 1Life Healthcare is disrupting healthcare from within the existing ecosystem by simultaneously addressing the frustrations and unmet needs of key stakeholders with a modernized healthcare membership model based on direct consumer enrollment as well as employer sponsorship.

The Davis Polk corporate team included partner Alan F. Denenberg and associate Donald K. Lang. Partner Michael Farber and associate Erin van Wesenbeeck provided tax advice. Counsel Bonnie Chen and associate Jesse L. Hallock provided intellectual property advice. Members of the Davis Polk team are based in the Northern California and New York offices.

Copy link to share post